BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7802423)

  • 1. [Etiopathogenesis of pituitary tumors].
    Morange-Ramos I; Pellegrini I; Caccavelli L; Brue T; Enjalbert A; Jaquet P
    Ann Endocrinol (Paris); 1994; 55(1):25-32. PubMed ID: 7802423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
    Herman V; Drazin NZ; Gonsky R; Melmed S
    J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of pituitary tumours.
    Herman-Bonert V; Fagin JA
    Baillieres Clin Endocrinol Metab; 1995 Apr; 9(2):203-23. PubMed ID: 7625983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.
    Pellegrini-Bouiller I; Morange-Ramos I; Barlier A; Gunz G; Figarella-Branger D; Cortet-Rudelli C; Grisoli F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3390-6. PubMed ID: 8784102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular alterations in pituitary tumors.
    Spada A; Vallar L; Faglia G
    Eur J Endocrinol; 1994 Jan; 130(1):43-52. PubMed ID: 7907260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and pathogenesis of pituitary adenomas.
    Faglia G
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():1-5. PubMed ID: 8396832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pituitary adenoma: mechanisms of endocrine oncogenesis].
    Bertherat J; Bertagna X
    Rev Prat; 1996 Jun; 46(12):1473-81. PubMed ID: 8881160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hormones, growth factors and their receptors in pituitary tumorigenesis.
    Ezzat S
    Brain Pathol; 2001 Jul; 11(3):356-70. PubMed ID: 11414477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The retinoblastoma gene in human pituitary tumors.
    Cryns VL; Alexander JM; Klibanski A; Arnold A
    J Clin Endocrinol Metab; 1993 Sep; 77(3):644-6. PubMed ID: 7690360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage.
    Mohammad HP; Abbud RA; Parlow AF; Lewin JS; Nilson JH
    Endocrinology; 2003 Oct; 144(10):4626-36. PubMed ID: 12960102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary tumour pathogenesis.
    Heaney AP
    Br Med Bull; 2005; 75-76():81-97. PubMed ID: 16684928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in studies of pituitary tumor pathogenesis.
    Minematsu T; Miyai S; Kajiya H; Suzuki M; Sanno N; Takekoshi S; Teramoto A; Osamura RY
    Endocrine; 2005 Oct; 28(1):37-41. PubMed ID: 16311408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGA2: A pituitary tumour subtype-specific oncogene?
    Fedele M; Palmieri D; Fusco A
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cAMP pathway and pituitary tumorigenesis.
    Lania A; Mantovani G; Spada A
    Ann Endocrinol (Paris); 2012 Apr; 73(2):73-5. PubMed ID: 22525824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropinomas.
    Chaidarun SS; Klibanski A
    Semin Reprod Med; 2002 Nov; 20(4):339-48. PubMed ID: 12536357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1.
    Weil RJ; Vortmeyer AO; Huang S; Boni R; Lubensky IA; Pack S; Marx SJ; Zhuang Z; Oldfield EH
    Clin Cancer Res; 1998 Jul; 4(7):1673-8. PubMed ID: 9676841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras mutations in human prolactinomas and pituitary carcinomas.
    Cai WY; Alexander JM; Hedley-Whyte ET; Scheithauer BW; Jameson JL; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1994 Jan; 78(1):89-93. PubMed ID: 8288721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus.
    Zhu J; Leon SP; Beggs AH; Busque L; Gilliland DG; Black PM
    J Clin Endocrinol Metab; 1994 Apr; 78(4):922-7. PubMed ID: 8157722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factors and human pituitary adenomas.
    Spada A; Lania A
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):63-8. PubMed ID: 12431797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.